PTSD Clinical Trials

Showing 41-60 of 414 trials

PTSD Treatment for Incarcerated Men and Women: AV

NCT07283757

This research will help identify if a PTSD treatment group, called Cognitive Processing Therapy (CPT), that is used in community settings is helpful in reducing PTSD symptoms among people who are incarcerated. The goal of CPT is to create a space for people to modify unhelpful beliefs related to trauma. A total of 692 participants will be enrolled from 6 locations and can expects to be on study for up to 24 weeks.

PTSD

University of Wisconsin, Madison900 participantsStarted Dec 2025

Madison, Wisconsin, United States

RECRUITINGPhase 2

Phase IIa Trial of a Selective Glucocorticoid Receptor Antagonist in the Treatment of Veterans With Posttraumatic Stress Disorder (PTSD) (Seven Study)

NCT04452500

The purpose of this study is to test the drug CORT108297, which blocks the hormone cortisol, for treatment of PTSD in Veterans, and establish a safety profile that will inform the design of future studies.

PTSD

VA Office of Research and Development40 participantsStarted Oct 2022

Tuscaloosa, Alabama, United States • San Francisco, California, United States

RECRUITINGNA

Advanced Wireless Augmented Reality-Enhanced Exposure Therapy for Posttraumatic Stress Disorder

NCT06740487

The goal of this trial is to test how augmented reality exposure therapy (ARET) may potentiate the effects of traditional exposure therapy administered to U.S. military personnel diagnosed with PTSD. 40 adult males and females over the age of 18 that have served, or are currently serving, in the U.S. military, with a current diagnosis of PTSD, will be recruited. Participants will be randomized into two groups: 20 participants will receive ARET + traditional ET, with the remaining 20 to receive traditional ET only. The main questions this trial aims to answer are: * what are the different clinical and psychosocial functioning outcomes between veterans/active-duty personnel with PTSD who receive ARET + traditional ET versus traditional ET only * what are the differences in acceptance and satisfaction of treatment, between ARET + traditional ET and the traditional ET-only group

PTSDPost Traumatic Stress Disorder

Wayne State University40 participantsStarted Sep 2025

Charleston, South Carolina, United States

PTSD Treatment for Incarcerated Men and Women: AV

Phase IIa Trial of a Selective Glucocorticoid Receptor Antagonist in the Treatment of Veterans With Posttraumatic Stress Disorder (PTSD) (Seven Study)

Advanced Wireless Augmented Reality-Enhanced Exposure Therapy for Posttraumatic Stress Disorder

Related Searches

Combining Esketamine and Prolonged Exposure Treatment for PTSD (Post Traumatic Stress Disorder)

Cervical Plexus Hydrodissection With D5W for PTSD

Development of the PTSD-iMPACT to Measure PTSD-Related Functional Impairment in Children and Adolescents - A Validation Study in Switzerland and Germany

Key Dimensions of PTSD and ED

Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research

Brief Prolonged Exposure Therapy Versus Clinical Standard to Reduce Posttraumatic Stress Post Spinal Cord Injury

The Feasibility and Examination of the Effects of Floatation-based REST on a Community Sample With PTSD

Transcranial Magnetic Stimulation in Veterans With PTSD

Treatment for Psychogenic Nonepileptic Seizures and Post-traumatic Stress Disorder Using Prolonged Exposure Therapy (PE) or Psychoeducation for PNES

Neural Connectivity During Therapy for Adolescent PTSD

Psilocybin-Assisted Randomized Therapy

Art Therapy and Emotional Well Being in Military Populations With Posttraumatic Stress Symptoms

Integrated Health Care for PTSD

Ayahuasca, Esketamine and PTSD

Examination of Glutamate and mGluR5 in Psychiatric Disorders

Peer-led Trauma Therapy for Re-entry

Feasibility of Group-Based Metacognitive Therapy for PTSD